{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-23-000011","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2023-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.809050+00:00","generated_at":"2026-06-20T16:33:16.865308+00:00","sec_items":["2.05","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Avanos launches 3-year transformation; CFO Greiner adds Chief Transformation Officer role; SVP Haydon to depart","bullets":["Three-year plan: combine Chronic Care & Pain franchises, exit low-margin products, cost management, and focused M&A.","CFO Michael Greiner assumes additional role of Chief Transformation Officer to lead the transformation.","Kerr Holbrook appointed SVP & Chief Commercial Officer, overseeing combined commercial organization.","William D. Haydon, SVP & GM Pain Franchise, to depart March 31, 2023; receives $972K severance plus up to $300K transition bonus.","Company currently unable to estimate total transformation costs; will file amended 8-K within four business days."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-23-000011","json":"https://secwatch.observer/filing/0001606498-23-000011.json","markdown":"https://secwatch.observer/filing/0001606498-23-000011.md","text":"https://secwatch.observer/filing/0001606498-23-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/0001606498-23-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/avns-20230110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T16:33:16.865308+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6cf26dafa8","claim":"William D. Haydon was terminated as Senior Vice President and General Manager, Pain Franchise at AVANOS MEDICAL, INC..","evidence_excerpt":"On January 10, 2023, the Company and William D. Haydon, the Company’s Senior Vice President and General Manager, Pain Franchise, entered into a Severance and Separation Agreement (the “Severance and Separation Agreement”) pursuant to which: (i) Mr. Haydon’s employment with the Company will terminate effective March 31, 2023 (the “Separation Date”);","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/0001606498-23-000011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Senior Vice President and General Manager, Pain Franchise"}],"fact_type":"executive_change"},{"claim_id":"e24ecc5576a31755e2571ec52149c42008b82a95","claim":"AVANOS MEDICAL, INC. announced a restructuring affecting Chronic Care and Pain franchises combined into single commercial organization; exit certain low-margin, low-growth product categories.","evidence_excerpt":"On January 10, 2023, Avanos Medical, Inc. (the “Company”) approved a three-year transformation process (the “Transformation Process”) pursuant to which the Company plans to: (i) combine its Chronic Care and Pain franchises into a single commercial organization focused on the Digestive Health and Orthopedic Pain & Recovery product categories; (ii) exit certain low-margin, low-growth product categories, including through targeted divestitures; (iii) undertake additional cost management activities to enhance the Company’s operating profitability; and (iv) pursue efficient capital allocation strategies, including through acquisitions that meet the Company’s strategic and financial criteria.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/0001606498-23-000011-index.htm","confidence":0.7,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Affected area","value":"Chronic Care and Pain franchises combined into single commercial organization; exit certain low-margin, low-growth product categories"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}